Insider: Palleiko Benjamin L CHIEF EXECUTIVE OFFICER - KalVista Pharmaceuticals, Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 395,189 | 0 | 395,189 |
| Value | $4,900,343.60 | $0.00 | $4,900,343.60 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 09/08/2025 | DDS | 7,294 | Direct | COM | $15.84 | $115,536.96 | 395,189 |
| 08/22/2025 | DDS | 10,940 | Direct | COM | $13.22 | $144,657.43 | 386,858 |
| 08/18/2025 | DDS | 4,409 | Direct | COM | $13.19 | $58,141.48 | 374,548 |
| 07/09/2025 | DDS | 32,979 | Direct | COM | $15.69 | $517,522.96 | 369,595 |
| 06/09/2025 | DDS | 7,169 | Direct | COM | $14.50 | $103,950.50 | 315,074 |
| 05/22/2025 | DDS | 9,999 | Direct | COM | $11.88 | $118,743.12 | 306,618 |
| 05/19/2025 | DDS | 3,808 | Direct | COM | $11.84 | $45,097.38 | 293,367 |
| 03/07/2025 | DDS | 6,669 | Direct | COM | $11.97 | $79,827.93 | 287,811 |
| 02/18/2025 | DDS | 5,104 | Direct | COM | $9.82 | $50,142.72 | 278,855 |
| 12/09/2024 | DDS | 7,627 | Direct | COM | $9.75 | $74,363.25 | 274,596 |
| 11/18/2024 | DDS | 14,400 | Direct | COM | $9.26 | $133,293.60 | 266,598 |
| 09/09/2024 | DDS | 7,352 | Direct | COM | $12.19 | $89,621.62 | 250,800 |
| 08/19/2024 | DDS | 14,215 | Direct | COM | $12.01 | $170,769.06 | 242,527 |
| 06/07/2024 | DDS | 7,465 | Direct | COM | $11.53 | $86,068.46 | 224,547 |
| 05/20/2024 | DDS | 21,959 | Direct | COM | $11.76 | $258,336.66 | 216,387 |
| 02/20/2024 | DDS | 22,802 | Direct | COM | $14.11 | $321,845.67 | 187,315 |
| 02/14/2024 | DDS | 40,855 | Direct | COM | $15.01 | $613,204.95 | 159,088 |
| 11/20/2023 | DDS | 13,008 | Direct | COM | $8.23 | $107,046.73 | 112,443 |
| 08/18/2023 | DDS | 13,067 | Direct | COM | $10.73 | $140,191.92 | 95,254 |
| 05/18/2023 | DDS | 4,037 | Direct | COM | $10.14 | $40,952.94 | 78,126 |
| 11/18/2022 | DDS | 722 | Direct | COM | $5.44 | $3,927.68 | 68,390 |
| 08/17/2022 | DDS | 725 | Direct | COM | $14.96 | $10,846.58 | 66,693 |
| 02/23/2021 | DDS | 1,256 | Direct | COM | $31.77 | $39,908.27 | 65,000 |
| 02/23/2021 | DDS | 22,093 | Direct | COM | $33.73 | $745,274.22 | 71,549 |
| 02/23/2021 | DDS | 1,000 | Direct | COM | $35.40 | $35,404.40 | 93,642 |
| 1 2 Next Last You are at page 1 of 2 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research